TransPerfect expands its portfolio by acquiring Sublime Subtitling

With decades of hard work and hands-on experience, TransPerfect has managed to become one of the largest global providers of technology and language solutions for companies worldwide. With over 5,000 global organizations employing its Globa....

Altran to launch a Digital Therapeutics Innovation Center in Boston

Digital therapeutics are evidence-based interventions conducted by advanced software programs to manage, treat or prevent clinical disorders. Its adoption has augmented the whole medical industry, making it simpler for practi....

Eli Lilly’s Phase 3 SEQUOIA trial fails to meet primary endpoint

Metastatic pancreatic cancer (MPC) is one of the most fatal cancers in the world. Pancreatic cancer is slated to be the third leading cause of cancer death in the U.S. and is expected to become the second leading cause of cancer-related dea....

Replimune gives an update on RP1 Clinical Development Program in CSCC

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer caused because of the uncontrolled growth of abnormal squamous cells. Currently, Libtayo is the only approved treatment in the Brazil and United States, ....

Kyowa Kirin’s NOURIANZ™ bags FDA nod for sale in the U.S.

Parkinson’s Disease is a progressive nervous system disorder that hampers the movement of the body by causing stiffness or slowness. Currently there are no definitive treatments for this clinical condition. However, various ....

GE Healthcare and Telix make some strides in prostate cancer imaging

Prostate cancer is one of the leading causes of deaths among men in the U.S. On an average, 1 out of 9 men are diagnosed with prostate cancer in their lifetime. Currently, there are several treatments which can prevent this cancer or s....

Pfizer reveals positive data from Phase 3 trial of ABROCITINIB

Atopic Dermatitis (AD) is a chronic skin disease characterized by skin barrier defects and inflammation. It results in itching, induration (hardening)/papulation (formulation of papules), and oozing/crusting and affects up to 10% of adults ....

Avacta inks Collaboration and Option Agreement with ADC Therapeutics

Among the most vital treatment breakthrough for cancer patients are therapies that targeted the site of tumors and regimens with novel combinations based on different mechanisms of action. New treatments are leading the way for po....

Annexon Biosciences reveals positive data from ANX007 Phase 1b trial

Glaucoma is an eye condition in which fluid pressure builds up within the eye affecting optic nerves. If not treated, a Glaucoma patient might lose partial vision or even go blind. The disease mostly occurs in older adults and cannot be cur....

FDA awards $15 million through 12 grants to fund new clinical trials

There is a substantial rise in the pharmaceutical firms conducting clinical trials to discover new therapies for a plethora of rare diseases. To encourage pharmaceutical firms to intensify their research efforts and to help them along with ....